Suppliers / LABORATE PHARMACEUTICALS INDIA

LABORATE PHARMACEUTICALS INDIA

Nigeria Updated 9 July 2026

LABORATE PHARMACEUTICALS INDIA is a finished-dose manufacturer based in Nigeria. It appears in 89 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), UZPHARM (UZ) and ARCSA (EC). Its GMP standing is certified by NAFDAC (NG), EMA and FDA (GH). Customs aggregates show $14K of exports covering 3 molecules to 2 destinations in 2025.

0
active US DMFs
0
valid CEPs
4
registered plants
89
filings across 6 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Sirmaur, India Not on file
51 INDUSTRIALS AREA GONDPUR PAONTA SAHIB HIMACHAL PRADESH INDIA, Nigeria Not on file
Panipat, Nigeria Not on file
Paonta Sahib, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
NAFDAC (NG) 57 4
UZPHARM (UZ) 12 None
ARCSA (EC) 9 None
FDA (GH) 5 1
MINSA (CR) 5 None
CDSCO (India) 1 None
EMA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $1.9M 13
2025 Not reported $14K 2
2024 Not reported $10K 2
2022 Not reported $7K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. LABORATE PHARMACEUTICALS INDIA comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts